The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients - Flisiak, R; Feinman, SV; Jablkowski, M; Horban, A; Kryczka, W; Pawlowska, M (Hepatology., 2009)
et al.